HHE determination report no. HHE-76-36-369, supplemental report, (follow up medical study to HHE- 76-36-339) Eagle Picher Industries, Inc., Joplin, Missouri.
Authors
Baker EL Jr.
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HHE 76-36-369, 1977 Mar; :1-10
Results are presented of outpatient diagnostic studies performed by a board-certified nephrologist in 19 of 53 affected workers in whom an earlier NIOSH Health Hazard Evaluation, No. 76-036-0339, of lead (7439921) exposure at the Eagle Picher Industries, Lead Chemicals Plant (SIC-2819) in Joplin, Missouri established the presence of high blood urea nitrogen levels. Physical examinations were generally within normal limits, but the results of kidney function tests, blood lead levels, erythrocyte protoporphyrin, urinary delta- aminolevulinic-acid (106605) levels, the presence of anemia and high urinary beta-2-microglobulin levels in 7 of the workers tested demonstrated a significantly increased prevalence of moderately severe kidney disease in employees at the Eagle Picher plant in Joplin, Missouri. All workers had a history of heavy lead exposure for 5-30 years. A positive relationship was established between the degree of renal dysfunction and duration of lead exposure. Periodic screening of other lead exposed workers is indicated to detect early lead related renal disease, which could best be accomplished by measuring creatinine clearance and urinary concentrating ability every six months.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.